New Strategy for Identifying Anticancer Candidates from Microbial DNA

Just now October 2, 2026 1 min read 📰 Phys.org

📋 Key Takeaway

Researchers have developed a strategy to recover biosynthetic information from fragmented metagenomic data, identifying candidates for antibacterial and anticancer testing. This work may have implications for healthcare advancements in Iran. The findings could enhance Iran's biopharmaceutical capabilities.

Researchers have developed a practical strategy for recovering biosynthetic information from fragmented metagenomic data. Through this work, the researchers identified and prioritized promising natural-product candidates with potential antibacterial or anticancer activity.